Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF

Experimental Cell Research

Volumn 315, Issue 13, 2009, Pages 2154-2164

  Kim, Woo Ho ^b   Lee, Sun Hee ^a   Jung, Myung Hwan ^a   Seo, Ji Heun ^b   Kim, Jin ^b   Kim, Min A ^b   Lee, You Mie ^a  

^a Kyungpook National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Co culture; DNA microarray; Immunohistochemistry; Migration; Neuropilin2; Proliferation; Tumor endothelial cell markers; VEGF

Indexed keywords

NEUROPILIN 2; VASCULOTROPIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR VASCULARIZATION; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 67349263560     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.04.018     Document Type: Article

References (41)

1. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
2. St Croix B., Rago C., Velculescu V., and Traverso G. et al. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
3. Nanda A., and St Croix B. Tumor endothelial markers: new targets for cancer therapy. Curr. Opin. Oncol. 16 (2004) 44-49
4. Boye E., Yu Y., Paranya G., Mulliken J.B., Olsen B.R., and Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J. Clin. Invest. 107 (2001) 745-752
5. Hida K., Hida Y., Amin D.N., Flint A.F., Panigrahy D., Morton C.C., and Klagsbrun M. Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res. 64 (2004) 8249-8255
6. Streubel B., Chott A., Huber D., Exner M., Jager U., Wagner O., and Schwarzinger I. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 351 (2004) 250-259
7. Amin D.N., Hida K., Bielenberg D.R., and Klagsbrun M. Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res. 66 (2006) 2173-2180
8. Borsi L., Balza E., Carnemolla B., Sassi F., and Castellani P. et al. Selective targeted delivery of TNFalpha to tumor blood vessels. Blood 102 (2003) 4384-4392
9. Halin C., Rondini S., Nilsson F., Berndt A., Kosmehl H., Zardi L., and Neri D. Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature. Nat. Biotechnol. 20 (2002) 264-269
10. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
11. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci. Publ. 157 (2004) 327-349
12. Sanz-Ortega J., Steinberg S.M., Moro E., et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol. Histopathol. 15 (2000) 455-462
13. Tanigawa N., Amaya H., Matsumura M., and Shimomatsuya T. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas. Br. J. Cancer 75 (1997) 566-571
14. Chen C.N., Cheng Y.M., Lin M.T., Hsieh F.J., Lee P.H., and Chang K.J. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann. Surg. 235 (2002) 512-518
15. Gong W., Wang L., Yao J.C., Jani J.A., Wei D., Aldape K.D., Xie K., Sawaya R., and Huang S. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin. Cancer Res. 11 (2005) 1386-1393
16. Chen C.N., Hsieh F.J., Cheng Y.M., Cheng W.F., Su Y.N., Chang K.J., and Lee P.H. The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett. 213 (2004) 73-82
17. Saito H., and Tsujitani S. Angiogenesis, angiogenic factor expression and prognosis of gastric carcinoma. Anticancer Res. 21 (2001) 4365-4372
18. Xie K., and Huang S. Regulation of cancer metastasis by stress pathways. Clin. Exp. Metastasis 20 (2003) 31-43
19. Kolodkin A.L., Levengood D.V., Rowe E.G., Tai Y.T., Giger R.J., and Ginty D.D. Neuropilin is a semaphoring III receptor. Cell 90 (1997) 753-762
20. Staton C.A., Kumar I., Reed M.W., and Brown N.J. Neuropilins in physiological and pathological angiogenesis. J. Pathol. 212 (2007) 237-248
21. Herzog Y., Kalcheim C., Kahane N., Reshef R., and Neufeld G. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 109 (2001) 115-119
22. Yuan L., Moyon D., Pardanaud L., Bréant C., Karkkainen M.J., Alitalo K., and Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129 (2002) 4797-4806
23. Wey J.S., Gray M.J., Fan F., Belcheva A., McCarty M.F., et al. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br. J. Cancer 25 (2005) 233-241
24. Kawakami T., Tokunaga T., Hatanaka H., Kijima H., et al. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer 15 (2002) 2196-2201
25. M.H. Jung, S.H. Lee, E.M. Ahn, Y.M. Lee, Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR2 signaling pathway. Carcinogenesis 30 (4) (2009) 655-661.
26. Shih I.M. The role of CD146 (Mel-CAM) in biology and pathology. J. Pathol. 189 (1999) 4-11
27. Yan X., Lin Y., Yang D., Shen Y., Yuan M., Zhang Z., Li P., Xia H., Li L., Luo D., Liu Q., Mann K., and Bader B.L. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 102 (2003) 184-191
28. Neidhart M., Wehrli R., Bruhlmann P., Michel B.A., Gay R.E., and Gay S. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum. 42 (1999) 622-630
29. Aalinkeel R., Nair M.P., Surfrin G., Mahajan S.D., Chandha K.C., Chawda R.P., and Schwartz S.A. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res. 64 (2004) 5311-5321
30. Gho Y.S., Kim P.N., Li H.C., Elkin M., and Kleinman H.K. Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res. 61 (2001) 4253-4257
31. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3 (1992) 65-71
32. Seaman S., Stevens J., Yang M.Y., Logsdon D., Graff-Cherry C., and St Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 11 (2007) 539-554
33. Pujades C., Guez-Guez B., and Dunon D. Melanoma Cell Adhesion Molecule (MCAM) expression in the myogenic lineage during early chick embryonic development. Int. J. Dev. Biol. 46 (2002) 263-266
34. Cerletti M., Molloy M.J., Tomczak K.K., Yoon S., M.F., et al. Melanoma cell adhesion molecule is a novel marker for human fetal myogenic cells and affects myoblast fusion. J. Cell Sci. 119 (2006) 3117-3127
35. Li G., Satyamoorthy K., and Herlyn M. Dynamics of cell interactions and communications during melanoma development. Crit. Rev. Oral. Biol. Med. 13 (2002) 62-70
36. Hellebrekers D.M., Castermans K., Vire E., Dings R.P., et al. Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications. Cancer Res. 66 (2006) 10770-10777
37. Shraga-Heled N., Kesseler O., Prahst C., Kroll J., Augustin H., and Neufeld G. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGF-2 receptor. FASEB J. 21 (2007) 915-926
38. Lang I., Pabst M.A., Hiden U., Blaschitz A., Dohr G., and Desoye T.Hahn.G. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur. J. Cell Biol. 82 (2003) 163-173
39. Lang I., Hoffmann C., Olip H., Pabst M.A., Hahn T., Dohr G., and Desoye G. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif. 34 (2001) 143-155
40. Winkler F., Kozin S.V., Tong R.T., Chae S.S., et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6 (2004) 553-563
41. Caunt M., Mak J., Liang W.C., Stawicki S., Pan Q., et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13 (2008) 331-342